Interesting that the cannacord valuation was raised from $1.35 to $1.90 (31st Jan 16) so they must have lowered it and then raised it.
Agree with most of what you said.
Just wonder why nothing has been said about the European market? Anyone?
Patent protection but wonder why they use 12 year DCF model w no value. Is that because of patents or is that a standard thing?
Wonder how much next cap raise will be.
Interesting that the cannacord valuation was raised from $1.35...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $4.303K | 2.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 40085905 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 91807222 | 63 |
View Market Depth
| Last trade - 10.57am 04/12/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
